S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LFST LifeStance Health Group Inc

7.40

0.09 (1.23%)

Nov 22 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

Date of Notice

11/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lisa K Miller

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

LifeStance Health (NASDAQ:LFST)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more LifeStance Health Charts.

LifeStance Health (NASDAQ:LFST)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more LifeStance Health Charts.

LifeStance Health Group Inc News

Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group
Wednesday 20 November 2024 (4 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 November 2024 (1 week ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 13 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 weeks ago) • Edgar (US Regulatory)

LifeStance Reports Third Quarter 2024 Results
Thursday 7 November 2024 (2 weeks ago) • GlobeNewswire Inc.

LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024
Thursday 17 October 2024 (1 month ago) • GlobeNewswire Inc.

LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election
Tuesday 8 October 2024 (2 months ago) • PR Newswire (US)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 25 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 13 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Friday 6 September 2024 (3 months ago) • Edgar (US Regulatory)

More LifeStance Health Group Inc News Articles

Global Developments (PK)

Baron Capital Enterprise (CE)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

Rennova Health (CE)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions